$599

Dexcom Business Updates; PharmaSens All-in-One Patch Pump Feasibility Study; Fractyl REVEAL-1 Data; Daewoong H2H SGLT2i Trial; MHRA Approves Rezdiffra

A series of cardiometabolic-related news items has been observed from Dexcom, PharmaSens, Fractyl Health, Daewoong Pharmaceutical, and Madrigal. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here